WHITFIELD ROY A
Reporting owner on Forms 3, 4 and 5, CIK 936728.
WHITFIELD ROY A reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-09-25.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| NEKTAR THERAPEUTICS CIK 906709 | director | 1 | 2026-09-25 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| NEKTAR THERAPEUTICS Common Stock | 2026-09-23 | A granted | +2,000 | $0 | 16,417 | Form 4 |
| NEKTAR THERAPEUTICS Common Stock, holding | 3,434 | Form 4 | ||||
| NEKTAR THERAPEUTICS Common Stock, holding | 1,334 | Form 4 | ||||
| NEKTAR THERAPEUTICS Stock Option, derivative | 2026-09-23 | A granted | +4,000 | $0 | 4,000 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001193125-26-403105 | NEKTAR THERAPEUTICS | 2026-09-25 |